Cargando…

Molecular Characterisation of Endogenous Vangl2/Vangl1 Heteromeric Protein Complexes

BACKGROUND: Mutations in the Planar Cell Polarity (PCP) core gene Vangl2 cause the most severe neural tube defects (NTD) in mice and humans. Genetic studies show that the Vangl2 gene genetically interacts with a close homologue Vangl1. How precisely Vangl2 and Vangl1 proteins interact and crosstalk...

Descripción completa

Detalles Bibliográficos
Autores principales: Belotti, Edwige, Puvirajesinghe, Tania M., Audebert, Stéphane, Baudelet, Emilie, Camoin, Luc, Pierres, Michel, Lasvaux, Lea, Ferracci, Géraldine, Montcouquiol, Mireille, Borg, Jean-Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460870/
https://www.ncbi.nlm.nih.gov/pubmed/23029439
http://dx.doi.org/10.1371/journal.pone.0046213
_version_ 1782245001769517056
author Belotti, Edwige
Puvirajesinghe, Tania M.
Audebert, Stéphane
Baudelet, Emilie
Camoin, Luc
Pierres, Michel
Lasvaux, Lea
Ferracci, Géraldine
Montcouquiol, Mireille
Borg, Jean-Paul
author_facet Belotti, Edwige
Puvirajesinghe, Tania M.
Audebert, Stéphane
Baudelet, Emilie
Camoin, Luc
Pierres, Michel
Lasvaux, Lea
Ferracci, Géraldine
Montcouquiol, Mireille
Borg, Jean-Paul
author_sort Belotti, Edwige
collection PubMed
description BACKGROUND: Mutations in the Planar Cell Polarity (PCP) core gene Vangl2 cause the most severe neural tube defects (NTD) in mice and humans. Genetic studies show that the Vangl2 gene genetically interacts with a close homologue Vangl1. How precisely Vangl2 and Vangl1 proteins interact and crosstalk has remained a difficult issue to address, with the main obstacle being the accurate discrimination of the two proteins, which share close sequence homology. Experimental evidence previously presented has been sparse and addressed with ectopically expressed proteins or with antibodies unable to biochemically discriminate Vangl1 from Vangl2, therefore giving rise to unclear results. METHODOLOGY AND MAIN FINDINGS: A highly specific monoclonal anti-Vangl2 antibody was generated and rigorously tested on both recombinant and extracted Vangl2 using surface plasmon resonance (SPR) analysis, western blot, and immunoprecipitation experiments. This antibody efficiently affinity-purified Vangl2 from cell lysates and allowed the unambiguous identification of endogenous Vangl2 by proteomic analysis. Vangl1 was also present in Vangl2 immunoprecipitates, establishing the first biochemical evidence for the existence of Vangl2/Vangl1 heterodimers at an endogenous level. Epitope-tagged Vangl2 and Vangl1 confirmed that both proteins interact and colocalize at the plasma membrane. The Vangl2 antibody is able to acutely assess differential expression levels of Vangl2 protein in culture cell lines, as corroborated with gene expression analysis. We characterised Vangl2 expression in the cochlea of homozygous and heterozygous Lp mutant mice bearing a point mutation within the C-terminal Vangl2 region that leads to profound PCP defects. Our antibody could detect much lower levels of Vangl2(Lp) protein in mutant mice compared to the wild type mice. CONCLUSION: Our results provide an in-depth biochemical characterisation of the interaction observed between Vangl paralogues.
format Online
Article
Text
id pubmed-3460870
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34608702012-10-01 Molecular Characterisation of Endogenous Vangl2/Vangl1 Heteromeric Protein Complexes Belotti, Edwige Puvirajesinghe, Tania M. Audebert, Stéphane Baudelet, Emilie Camoin, Luc Pierres, Michel Lasvaux, Lea Ferracci, Géraldine Montcouquiol, Mireille Borg, Jean-Paul PLoS One Research Article BACKGROUND: Mutations in the Planar Cell Polarity (PCP) core gene Vangl2 cause the most severe neural tube defects (NTD) in mice and humans. Genetic studies show that the Vangl2 gene genetically interacts with a close homologue Vangl1. How precisely Vangl2 and Vangl1 proteins interact and crosstalk has remained a difficult issue to address, with the main obstacle being the accurate discrimination of the two proteins, which share close sequence homology. Experimental evidence previously presented has been sparse and addressed with ectopically expressed proteins or with antibodies unable to biochemically discriminate Vangl1 from Vangl2, therefore giving rise to unclear results. METHODOLOGY AND MAIN FINDINGS: A highly specific monoclonal anti-Vangl2 antibody was generated and rigorously tested on both recombinant and extracted Vangl2 using surface plasmon resonance (SPR) analysis, western blot, and immunoprecipitation experiments. This antibody efficiently affinity-purified Vangl2 from cell lysates and allowed the unambiguous identification of endogenous Vangl2 by proteomic analysis. Vangl1 was also present in Vangl2 immunoprecipitates, establishing the first biochemical evidence for the existence of Vangl2/Vangl1 heterodimers at an endogenous level. Epitope-tagged Vangl2 and Vangl1 confirmed that both proteins interact and colocalize at the plasma membrane. The Vangl2 antibody is able to acutely assess differential expression levels of Vangl2 protein in culture cell lines, as corroborated with gene expression analysis. We characterised Vangl2 expression in the cochlea of homozygous and heterozygous Lp mutant mice bearing a point mutation within the C-terminal Vangl2 region that leads to profound PCP defects. Our antibody could detect much lower levels of Vangl2(Lp) protein in mutant mice compared to the wild type mice. CONCLUSION: Our results provide an in-depth biochemical characterisation of the interaction observed between Vangl paralogues. Public Library of Science 2012-09-28 /pmc/articles/PMC3460870/ /pubmed/23029439 http://dx.doi.org/10.1371/journal.pone.0046213 Text en © 2012 Belotti et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Belotti, Edwige
Puvirajesinghe, Tania M.
Audebert, Stéphane
Baudelet, Emilie
Camoin, Luc
Pierres, Michel
Lasvaux, Lea
Ferracci, Géraldine
Montcouquiol, Mireille
Borg, Jean-Paul
Molecular Characterisation of Endogenous Vangl2/Vangl1 Heteromeric Protein Complexes
title Molecular Characterisation of Endogenous Vangl2/Vangl1 Heteromeric Protein Complexes
title_full Molecular Characterisation of Endogenous Vangl2/Vangl1 Heteromeric Protein Complexes
title_fullStr Molecular Characterisation of Endogenous Vangl2/Vangl1 Heteromeric Protein Complexes
title_full_unstemmed Molecular Characterisation of Endogenous Vangl2/Vangl1 Heteromeric Protein Complexes
title_short Molecular Characterisation of Endogenous Vangl2/Vangl1 Heteromeric Protein Complexes
title_sort molecular characterisation of endogenous vangl2/vangl1 heteromeric protein complexes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460870/
https://www.ncbi.nlm.nih.gov/pubmed/23029439
http://dx.doi.org/10.1371/journal.pone.0046213
work_keys_str_mv AT belottiedwige molecularcharacterisationofendogenousvangl2vangl1heteromericproteincomplexes
AT puvirajesinghetaniam molecularcharacterisationofendogenousvangl2vangl1heteromericproteincomplexes
AT audebertstephane molecularcharacterisationofendogenousvangl2vangl1heteromericproteincomplexes
AT baudeletemilie molecularcharacterisationofendogenousvangl2vangl1heteromericproteincomplexes
AT camoinluc molecularcharacterisationofendogenousvangl2vangl1heteromericproteincomplexes
AT pierresmichel molecularcharacterisationofendogenousvangl2vangl1heteromericproteincomplexes
AT lasvauxlea molecularcharacterisationofendogenousvangl2vangl1heteromericproteincomplexes
AT ferraccigeraldine molecularcharacterisationofendogenousvangl2vangl1heteromericproteincomplexes
AT montcouquiolmireille molecularcharacterisationofendogenousvangl2vangl1heteromericproteincomplexes
AT borgjeanpaul molecularcharacterisationofendogenousvangl2vangl1heteromericproteincomplexes